Pharmacokinetics of Ambroxol Sustained Release (Mucosolvan(®) Retard) Compared with Other Formulations in Healthy Volunteers

INTRODUCTION: Ambroxol is used in the treatment of acute and chronic respiratory conditions characterized by abnormal mucus secretion and impaired mucus transport and is available in a variety of formulations. This study aimed to compare the steady-state (SS) pharmacokinetic characteristics of exten...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Pulm Ther
Hlavní autoři: Ollier, Celine, Sent, Ulrike, Mesquita, Margarida, Michel, Martin C.
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer Healthcare 2020
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7229136/
https://ncbi.nlm.nih.gov/pubmed/32372294
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s41030-020-00116-7
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky